Academy

Sponsors are now working with more data sources—an average of five sources per trial—than ever before. As a result, data chaos, data integration, and access are significant issues, especially for emerging and mid-market biopharma companies that often rely heavily on outsourced models for data acquisition, management, and clinical services.

The use and adoption of patient-centric Decentralized Trials platforms continue to increase in clinical research. As more companies incorporate decentralized trial models and technology, the elluminate clinical data platform accelerates these efforts preventing data integration, review, and monitoring challenges.

The elluminate platform is designed to decrease the manual work associated with integrating and standardizing clinical data from disparate sources and systems, and automates publishing these data to data reviewers and clinical operations team members.

Medical review of clinical trial data is a critical component of the clinical development process. The process of medical monitoring requires access and analysis of all clinical data sources in order to understand the holistic patient experience along with data trending and exploration capabilities.

A Clinical Trial Management System (CTMS) provides tremendous value for the clinical operations teams responsible for running the trials, as well as for management oversight and all associated support units.

The elluminate Clinical Data Platform automates the clinical data pipeline for Life Sciences Companies enabling the ingestion of data across numerous sources and systems.